Back to results
US 9,315,462 B2Granted
Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
AssigneeNivalis Therapeutics, Inc.
InventorsXicheng Sun, Jian Qiu, Adam Stout
Life of this patent
Estimating the term…
Abstract
The present invention is directed to novel quinoline compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.
Claims14
The method of preparing a compound of Formula 1c, or a salt thereof,
- the method comprising the step of coupling a compound of Formula 1a
- with a compound Formula 1b
- wherein:
- m is selected from the group consisting of 0 and 1;
- R1 is independently selected from the group consisting of chloro, fluoro, bromo, cyano, and methoxy;
- R2b and R2c are independently selected from the group consisting of hydrogen, chloro, fluoro, methyl, trifluoromethyl, cyano, methoxy, and N(CH3)2;
- RA and RB are independently selected from the group consisting of H and Me;
- RC and RD are independently or together a group that can by hydrolyzed to hydroxyl;
- n is selected from the group consisting of 0 and 1;
- and
- R3 is independently selected from the group consisting of fluoro, chloro, bromo, methyl, trifluoromethyl, cyano, methoxy, and N(CH3)2.
8 more elements
Dependencies are inferred from the claim text.